CVS investors get the chance to participate in CVS Health Corporation’s fraud investigation with law firm Schall

Schall Law Firm, a national law firm focused on shareholder rights litigation, announces that it is investigating claims alleging violations of the securities laws on behalf of investors of CVS Health Corporation (“CVS” or “the Company”) (NYSE: CVS).

The investigation focuses on whether the Company made false and/or misleading statements and/or failed to disclose information relevant to investors. CVS failed to accurately forecast trends in medical costs and health care utilization. The Company was forced to incur material costs because of its ineffective forecasting. The Company overstated the profitability of its Health Care Benefits division. Despite its insurance, the Company’s profits from other business segments were not sufficient to cover the rising costs of its Health Care Benefits segment. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CVS, investors suffered.